Student Work
A Comparative Analysis of Drug Testing and Regulations with a Focus on Antibody Drug Conjugate (ADC) Approval
PublicContenu téléchargeable
open in viewerThe goal of this project, sponsored by Hangzhou DAC Biotech, was to conduct a comparative analysis of the drug approval process for three agencies, with a focus on antibody drug conjugates (ADCs). The results show that the FDA has the fastest approval, the EMA has the safest approval, and the CFDA has the least expensive approval. This report concludes with an evaluation of each of the three agencies approval processes and recommendations for small biotech and pharmaceutical companies seeking approval for newly developed drugs such as antibody drug conjugates.
- This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.
- Creator
- Subject
- Publisher
- Identifier
- E-project-121415-221927
- Mot-clé
- Advisor
- Year
- 2015
- Center
- Sponsor
- Date created
- 2015-12-14
- Emplacement
- Hangzhou
- Resource type
- Rights statement
- Dernière modification
- 2022-04-01
Relations
- Dans Collection:
Contenu
Articles
La vignette | Titre | Visibilité | Embargo Release Date | actes |
---|---|---|---|---|
DTR1_IQP_Final_Paper.pdf | Public | Télécharger |
Permanent link to this page: https://digital.wpi.edu/show/pz50gw326